Estall Jennifer L, Yusta Bernardo, Drucker Daniel J
Department of Laboratory Medicine and Pathobiology, University of Toronto, The Banting and Best Diabetes Centre, Toronto General Hospital, Toronto, Canada M5G 2C4.
Mol Biol Cell. 2004 Aug;15(8):3673-87. doi: 10.1091/mbc.e03-11-0825. Epub 2004 May 28.
The intestinotrophic and cytoprotective actions of glucagon-like peptide-2 (GLP-2) are mediated by the GLP-2 receptor (GLP-2R), a member of the class II glucagon-secretin G protein-coupled receptor superfamily. Although native GLP-2 exhibits a short circulating half-life, long-acting degradation-resistant GLP-2 analogues are being evaluated for therapeutic use in human subjects. Accordingly, we examined the mechanisms regulating signaling, internalization, and trafficking of the GLP-2R to identify determinants of receptor activation and desensitization. Heterologous cells expressing the transfected rat or human GLP-2R exhibited a rapid, dose-dependent, and prolonged desensitization of the GLP-2-stimulated cAMP response and a sustained GLP-2-induced decrease in levels of cell surface receptor. Surprisingly, inhibitors of clathrin-dependent endocytosis failed to significantly decrease GLP-2R internalization, whereas cholesterol sequestration inhibited ligand-induced receptor internalization and potentiated homologous desensitization. The hGLP-2R localized to both Triton X-100-soluble and -insoluble (lipid raft) cellular fractions and colocalized transiently with the lipid raft marker caveolin-1. Although GLP-2R endocytosis was dependent on lipid raft integrity, the receptor transiently associated with green fluorescent protein tagged-early endosome antigen 1-positive vesicles and inhibitors of endosomal acidification attenuated the reappearance of the GLP-2R on the cell surface. Our data demonstrate that GLP-2R desensitization and raft-dependent trafficking represent distinct and independent cellular mechanisms and provide new evidence implicating the importance of a clathrin- and dynamin-independent, lipid raft-dependent pathway for homologous G protein-coupled receptor internalization.
胰高血糖素样肽-2(GLP-2)的肠营养和细胞保护作用由GLP-2受体(GLP-2R)介导,GLP-2R是II类胰高血糖素-促胰液素G蛋白偶联受体超家族的成员。尽管天然GLP-2的循环半衰期较短,但长效抗降解GLP-2类似物正在进行人体治疗用途的评估。因此,我们研究了调节GLP-2R信号传导、内化和运输的机制,以确定受体激活和脱敏的决定因素。表达转染大鼠或人GLP-2R的异源细胞对GLP-2刺激的cAMP反应表现出快速、剂量依赖性和延长的脱敏作用,以及GLP-2诱导的细胞表面受体水平持续下降。令人惊讶的是,网格蛋白依赖性内吞作用的抑制剂未能显著降低GLP-2R的内化,而胆固醇螯合则抑制配体诱导的受体内化并增强同源脱敏。人GLP-2R定位于Triton X-100可溶性和不溶性(脂筏)细胞组分,并与脂筏标记物小窝蛋白-1短暂共定位。尽管GLP-2R的内吞作用依赖于脂筏完整性,但该受体与绿色荧光蛋白标记的早期内体抗原1阳性囊泡短暂相关,内体酸化抑制剂减弱了GLP-2R在细胞表面的重新出现。我们的数据表明,GLP-2R脱敏和脂筏依赖性运输代表了不同且独立的细胞机制,并提供了新的证据,表明网格蛋白和发动蛋白非依赖性、脂筏依赖性途径对同源G蛋白偶联受体内化的重要性。